Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 74   

Articles published

TENX 2.46 +0.05 (2.07%)
price chart
Below Moving Averages, This Stock Can't Reverse Trend: Tenax Therapeutics, Inc ...
Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX) have been on a consistent downtrend as of late, causing concern for stock owners.
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics (NASDAQ: TENX)
MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the Company ...
Beleagured Morrisville drug developer changes name, sharpens focus  Triangle Business Journal
Related articles »  
Option Market: Tenax Therapeutics Inc Risk Hits An Extreme High
The option market reflects substanially more risk in the next 30 calendar days for Tenax Therapeutics Inc (NASDAQ:TENX) than on average.
Tenax Therapeutics Provides Update of Phase 3 LEVO-CTS Trial for LCOS
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today provided an update for its ongoing ...
Tenax Therapeutics Provides Clinical Update for Lead Candidate Levosimendan
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today provided a detailed clinical ...
Investor Watch: Earnings and Street Rating Review for Tenax Therapeutics, Inc ...
Investors and analysts will be waiting to see if the company hits or misses earnings projections after the next earnings report. Tenax Therapeutics, Inc. (NASDAQ:TENX) is scheduled to next post quarterly results on or around 2016-09-14. The company ...
Tenax Therapeutics Highlights Completion of Enrollment for LeoPARDS Trial by ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today highlighted that Imperial College ...
Tenax Therapeutics Inc Stock Momentum Hits Strength
This is a momentum stock rating analysis for Tenax Therapeutics Inc (NASDAQ:TENX) . The company has a four bull momentum rating which indicates some strength.
Tenax Therapeutics, Inc. (TENX) Broker Price Targets For The Coming Week
01/20/2015 - Tenax Therapeutics, Inc. had its “buy” rating reiterated by analysts at MLV & Co. They now have a USD 7 price target on the stock.
Tenax Therapeutics, Inc. (NASDAQ:TENX) Consolidated Diluted EPS Stands At ...  Equities Focus
Tenax Therapeutics Inc (NASDAQ:TENX) director Ronald Blanck, Buys $6080 in Stock
After the disclosing of a document filled with U.S. Security & Exchange Commission; a new insider trading deal became apparent.